Outperforming in an Onco-Hematology Clinical Trial
Meticulously selected by Accell, Russian sites twice outperformed enrollment in Western European sites and 6 times in US sites.
Inventive operational strategy for a cardiology rescue study
Phase III clinical trial in cardiology for a global top-10 pharmaceutical company. Accell recruited 130% of promised patients before the deadline for patient recruitment.
Oncology Phase III Rescue Study
After 16 months of slow recruitment, Sponsor addressed Accell to add an emergency country to rescue the study. Accell recruited 21.6% of total patients in just 6 months.
Top Recruiters in Ulcerative Colitis Phase III Study
Accell recruited 84% of total patients, with only 65% of a total number of study sites, and made sure the Sponsor ended recruitment earlier than planned and faster entered the market.
Recent Comments